Toll Brothers, Inc. (TOL)

Elevation Oncology Revenue

Toll Brothers had revenue of $2.74B in the quarter ending April 30, 2025, a decrease of -3.47%. This brings the company's revenue in the last twelve months to $10.66B, up 1.59% year-over-year. In the fiscal year ending October 31, 2024, Toll Brothers had annual revenue of $10.85B with 8.52% growth.

• Revenue (ttm): $10.66B
• Revenue Growth: +1.59%
• P/S Ratio: 1.19
• Revenue / Employee: $2,175,431
• Employees: 4,900
• Market Cap: 12.27B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2024	10.85B	851.80M	8.52%
Oct 31, 2023	9.99B	-280.62M	-2.73%
Oct 31, 2022	10.28B	1.49B	16.90%
Oct 31, 2021	8.79B	1.71B	24.20%
Oct 31, 2020	7.08B	-146.31M	-2.03%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.